In Brief: Perkin-Elmer/Hitachi
This article was originally published in The Gray Sheet
Forge strategic partnership to develop and manufacture electrophoresis-based genetic analysis instrumentation. Under the terms of the deal, announced Feb. 18, Perkin-Elmer and Hitachi will jointly develop automated systems to be manufactured by Hitachi and marketed primarily by Perkin-Elmer's Applied Biosystems Division. Perkin-Elmer will hold exclusive marketing rights worldwide, except Japan, where the two firms will jointly market the devices...
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.